Billings / RPOs disappoint and, unsurprisingly, forward revenue guidance follows. This won’t cut it with shares now -10% in response. 2Q, 3Q and full year actuals vs. Consensus:
Keep reading with a 7-day free trial
Subscribe to Earnings Edge to keep reading this post and get 7 days of free access to the full post archives.